Why submit to Japanese Journal of Clinical Oncology?
Japanese Journal of Clinical Oncology (JJCO) is an online only (as of January 2018) multidisciplinary journal for clinical oncologists. JJCO publishes high quality articles on medical oncology, clinical trials, radiology, surgery, basic research, epidemiology, and palliative care. Whilst it contributes to international scientific knowledge, it places particular emphasis on the Asian region.
Submit today and join our author community.
Publish your research with Japanese Journal of Clinical Oncology and benefit from:
Expert Editorial Board and Reviewer Board
-
Your work benefits from the support of our expert editorial board and their impressive combined experience
-
You can be confident that your findings are published in their best condition thanks to our quality reviewer board
Straightforward Submissions Processes
-
Using ScholarOne Manuscripts makes submitting straightforward
-
Clear Author Guidelines
Reputation and Awards
-
1.9 2023 Impact Factor (Clarivate, 2024)
-
Research that commands attention - 129 mentions of research output in 2022 (Altmetric)
-
A privilege of Free Access publication granted to one article per issue (Editor-in-Chief’s selection)
-
If you publish with JJCO, your work will be eligible for the JJCO Awards. Winners receive additional promotional opportunities, certificates, and prizes.
Amplified Research
-
JJCO gains from robust marketing efforts that support the promotion of your research. These may include email outreach, featuring your article alongside other thematically matched content in online subject collections, or social media promotion, as appropriate.
-
JJCO content is indexed in various services, including several ProQuest databases, EMBASE, and Global Health, helping more people find your research.
-
JJCO is part of Oxford University Press’ Oncology titles list, making it ripe for cross-promotional opportunities, such as the Oxford Oncology Hub.
Wide range of article types accepted
-
JJCO publishes manuscripts that describe new findings in any area related to clinical oncology. Various article types are accepted, including original articles, clinical trial notes, and technical notes. Find out more about the various accepted article types here.
Options for Open Access
-
JJCO is a hybrid journal, widely available to many institutional subscribers, but if you prefer, or your funder requires it, you can also opt to publish open-access. You may even be able to refer the OA Article Processing Charge (APC) to your institute via one of our Read & Publish arrangements. Find out more about OA options and other licensing agreements here.
